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1. Introduction 
Bone formation in large defects and non-union fractures present a significant challenge for orthopaedic 
clinicians and researchers [1]. In the past, bone grafting techniques have been used as a gold standard to 
stimulate bone tissue formation and repair in large defects but these are not without complications and 
limitations such as risk of infection, disease transmission and immune response. To overcome these 
drawbacks, tissue engineering has aimed to develop bone substitutes to replace damaged, diseased or 
aging tissue. These bone substitutes are designed to support the chemotaxis, proliferation and 
differentiation of bone progenitor cells as well as being a biochemical agent delivery system, making 
them a promising alternative to bone grafting techniques. Of all the biochemical agents that have been 
identified to support bone formation, bone morphogenetic proteins 2 (BMP-2) is widely recognized to 
be one of the most powerful osteoinductive factors for bone regeneration [1-3]. Recombinant human 
bone morphogenetic protein-2 (rhBMP-2) marketed as Infuse® (Medtronic) is approved for clinical use 
in North America and Europe [1].  
 
However, these delivery systems also have limitations such as structural weakness and uncontrolled 
delivery of BMP-2 dose [2, 4]. An additional major drawback of these systems is limited understanding 
on the fundamental mechanism of BMP-2 induced bone formation. Therefore, due to their widespread 
medical use, there is increasing demand to design and develop optimized delivery systems to reduce the 
amounts of BMP-2 use along with providing better structural support resulting in high bone formation.  
 
Over the past few years, several mechanoregulatory models [5-7], a bioregulatory model [8] and several 
mechanobioregulatory models combining both mechanical and biological factors [9-12] have been 
proposed for fracture healing. More recently, in silico models [13-15]  have been proposed that provide 
a better understanding of large bone union/non-union healing. The current computational models [15] 
of bone formation and regeneration typically focus on the orthotopic environment. In this study, we 
implemented a previously reported mathematical model [13] to elucidate the in vivo bone formation 
capacity of BMP delivery systems in an ectopic environment and more specifically, to investigate the 
influence of  BMP-2 dose.  
 
2. Materials and Methods 
2.1 Mathematical model 
The bone regeneration outcome of a BMP-2 delivery system was modelled using a previously 
established model [13] which described the spatiotemporal evolution of mesenchymal stem cell density 
(cm), fibroblast density (cf), chondrocyte density (cc), osteoblast density (cb), fibrous extracellular matrix 
density (mf), cartilaginous matrix density (mc), bone extracellular matrix density (mb), generic osteo-
chondrogenic growth factor concentration (gbc), vascular growth factor concentration (gv) and 
concentration of oxygen (n) (Fig.1). A set of 10 partial differential equations (PDEs) of the taxis-
reaction-diffusion type captured the various key processes of bone regeneration at the tissue level. The 
model does not include bone remodelling. 
  
Figure 1: Schematic overview of the multiscale model indicating the scale separation map of the modelled 
processes at different spatial and temporal scales. 
 
The general structure of the set of continuous equations is given by: 
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where t represents time,  ?⃗? the space and 𝑐𝑚(t, ?⃗?) the density of a migrating cell type (mesenchymal 
stem cells and fibroblasts). 𝑐(t, ?⃗?) represents the vector of the other concentrations, ECM densities, 
growth factor concentrations and oxygen concentrations for which no directed migration is modelled. 
𝐷𝑐𝑚(𝑐𝑚) and  𝐷 are the diffusion coefficients. 𝑓𝑖(𝑐) represents the taxis coefficients for both chemotaxis 
and haptotaxis. 𝑓0(𝑐𝑚, 𝑐) and ?⃗?(𝑐𝑚, 𝑐) are reaction terms describing cell differentiation, proliferation 
and decay and matrix and growth factor production and decay. Detailed information, including the 
complete set of equations, parameter values and implementation details can be found in Carlier et al. 
[13], Geris et al. [11] and Peiffer et al. [12]. The formation of the blood vessel network, was modelled 
using the discrete agent-based model of Bentley et al. [16] details (including the tip cell movement, 
vessel sprouting and anastomosis) on which can be found in Carlier et al. [13]. 
 
2.2 Geometry domain, boundary (BC) and initial conditions (IC) 
At the start of the simulation, cm (0.02) and n (3.7%) were present throughout the defect. The various 
initial conditions for gbc (0, 0.1, 0.5 and 1) that were also present throughout the defect were used in this 
study. Suitable boundary conditions were prescribed to the model. No-flux boundary conditions were 
applied for all components of the PDE system with diffusion or taxis terms, except for cm (0.02) and cf 
(0.02) for which Dirichlet boundary conditions were applied for a specified period of time (Fig. 2). 
 
Figure 2: Geometrical domain, initial and boundary conditions. 
 3. Results 
The model is able to reproduce the sequential events observed experimentally (not shown here) during 
bone regeneration process at the intracellular level (signalling of Notch1, actin and D114), cellular level 
(angiogenesis) and tissue level (migration, proliferation, differentiation, matrix production). Most 
importantly the model is able to simulate the influence of of BMP dose on ectopic bone formation (Fig. 
3).  
 
Figure 3: Depicts BMP-2 dose (gbc = 0, 0.1, 0. 5, 1) influence on ectopic bone formation at day 0, 8, 16, 24 and 
32. 
 
The results show that the bone formation depends on the BMP concentration in a Gaussian manner with 
gbc = 0.5 being the peak which also had the highest amount of vessel formation. For gbc = 0, no 
differentiation and proliferation of cm was observed, thus not leading to any cartilage or bone formation 
(Table 1).   
 
Table 1: Tissue formation predicted by the model for various initial conditions of gbc at day 35. 
Initial condition for gbc Fibrous tissue (%) Cartilage tissue (%) Bone tissue (%) 
0 100 0 0 
0.1 80.4 0 19.6 
0.5 0 3.86 96.1 
1 21.3 25.7 53 
 
4. Discussion and Conclusion  
In this study, we described the implementation of previously reported in silico bioregulatory model [13] 
to investigate the influence of BMP dose on ectopic bone formation. This semi-quantitative model was 
able to capture both the intramembranous and the endochondral ossification, thus simulating a BMP 
device. The results obtained in this study illustrate the potential of mathematical models as research 
tools to design more efficient BMP dose-dependent carriers for bone tissue engineering applications.  
 
From the model, it can be deduced that the initial high value of gbc = 1 leads to higher differentiation of 
cm, thus resulting in lower amount of cm available for proliferation. When the initial concentration of gbc 
is 0.5, it leads to enough cm which is available for both proliferation and differentiation resulting in high 
bone formation. But initially low concentration of growth factors (such as gbc = 0 or 0.1) results in no or 
low bone formation due to low cell differentiation. Additionally, oxygen (n) influences cell 
differentiation and proliferation but is also consumed by cells at the same time. Therefore, it can be 
stated that the maximum bone formation can obtained by having optimum concentrations of various 
cells at any given time which can be regulated by growth factors (gbc). 
 
In the future, the performance of this semi-quantitative mathematical model will be corroborated by 
experimental results reported in the literature [17] for bone formation in ectopically implanted BMP-2 
delivery systems. Moreover, the model will be applied to design optimal combinations of BMP-2 dosage 
and carrier volume with the aim of maximizing the amount of ectopic bone formation. This model has 
significant potential to facilitate understanding and development of complex bone tissue engineering 
substitutes (i.e. carriers with cells and/or growth factors) by investigating numerous design parameters 
and avoiding excessive experimentation, thus saving time and resources. Finally, this study is a first step 
towards mathematical modelling of BMP-delivery system in an ectopic environment. 
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